Search

everythinglearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

The peptide GPIGS helps hair cells grow and speeds up hair regrowth in mice.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

5α-reduced progestogens may reduce mood issues and brain damage linked to HIV-1 Tat.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

Finasteride and intense pulsed light effectively reduce unwanted facial hair in women, but may not be cost-effective.

Corticosteroids regrow hair better and faster than pentoxifylline for alopecia areata.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Injecting patients' own PRP into their thyroid improved thyroid function and symptoms in most hypothyroidism cases.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Polynucleotide gel injections help reduce hair loss and increase hair thickness in people with pattern hair loss, with few side effects.